Ketek sparks calls to stiffen antibiotic trials (Pittsburgh Post-Gazette)
Controversy over the Food and Drug Administration's handling of the antibiotic Ketek is focusing new attention on the way the agency evaluates the efficacy of antibiotics.

Panacos launches midstage study of HIV drug (Washington Business Journal)
Panacos Pharmaceuticals has begun a midstage human clinical trial of its HIV drug candidate, which will help the company choose the best dose of the drug for late-stage testing.